Prolonged Excretion Half-Life of 11-nor-9-Carboxy-δ 9-THC Following Cessation in a Chronic, Heavy Marijuana User: Implications for Liver Transplant Assessment

Psychosomatics

Volumn 52, Issue 2, 2011, Pages 190-193

  Chaiffetz, David ^a   DiMartini, Andrea F ^a,b   Venkataramanan, Raman ^b,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; CREATININE; TETRAHYDROCANNABINOLIC ACID; TETRAHYDROCANNABINOL;

ADULT; ALCOHOL LIVER DISEASE; ALCOHOLISM; ARTICLE; CANNABIS ADDICTION; CASE REPORT; DRUG EXCRETION; DRUG HALF LIFE; GENOTYPE; GOLD STANDARD; HEPATITIS C; HUMAN; IMMUNOASSAY; LIVER TRANSPLANTATION; MALE; MASS FRAGMENTOGRAPHY; OBESITY; SMOKELESS TOBACCO; URINALYSIS; CANNABIS SMOKING; HALF LIFE TIME; METABOLISM; METHODOLOGY; MIDDLE AGED; SUBSTANCE ABUSE;

HALF-LIFE; HEPATITIS C, CHRONIC; HUMANS; LIVER TRANSPLANTATION; MALE; MARIJUANA SMOKING; MIDDLE AGED; SUBSTANCE ABUSE DETECTION; TETRAHYDROCANNABINOL;

EID: 79960989185     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1016/j.psym.2010.12.005     Document Type: Article

References (11)

1. The National Survey on Drug Use and Health (NSDUH), (Substance Use and Mental Health Services Administration an agency of the Dept. of Health and Human Services). http://www.samhsa.gov.
2. Musshoff F., Madea B. Review of biologic matrices (urine, blood, hair) as indicators of recent or ongoing cannabis use. Ther Drug Monit 2006, 28:155-163.
3. Perez-Reyes M., Di Guiseppi S., Mason A.P., et al. Passive inhalation of marihuana smoke and urinary excretion of cannabinoids. Clin Pharmacol Ther 1983, 34:36-41.
4. Cone E.J., Johnson R.E., Darwin W.D., et al. Passive inhalation of marijuana smoke: Urinalysis and room air levels of δ-9-tetrahydrocannabinol. J Anal Toxicol 1987, 11:89-96.
5. Manno J.E., Ferslew K.E., Manno B.R. Urine excretion patterns of cannabinoids and the clinical application of the EMIT d.a.u. cannabinoid urine assay for substance abuse treatment. The cannabinoids: Chemical, pharmacologic and therapeutic aspects 1984, 281-290. Academic Press, New York. S. Augurell, W.L. Dewey, R. Willette (Eds.).
6. Huestis M.A., Cone E.J. Differentiating new marijuana use from residual drug excretion in occasional marijuana users. J Anal Toxicol 1998, 22:445-454.
7. Lafolie P., Beck O., Blennow G., et al. Importance of creatinine analyses of urine when screening for abused drugs. Clin Chem 1991, 37:1927-1931.
8. Ellis G.M., Mann M.A., Judson B.A., et al. Excretion patterns of cannabinoid metabolites after last use in a group of chronic users. Clin Pharmacol Ther 1985, 38:572-578.
9. Huestis M.A. Pharmacokinetics of THC in inhaled and oral preparations. Marihuana and medicine 1999, 105-116. Humana Press, Totowa. G. Nahas, K.M. Sutin, D.J. Harvery (Eds.).
10. Nahas G.G. The pharmacokinetics of THC in fat and brain: Resulting functional responses to marihuana smoking. Hum Psychopharmacol Clin Exp 2001, 16:247-255.
11. Coffman K. The debate about marijuana usage in transplant candidates: Recent medical evidence on marijuana health effects. Curr Opin Organ Transplant 2008, 13:189-195.